Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 7, 2019; 25(1): 118-137
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.118
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Nomogram for predicting the probability of pathological complete response for all patients. MRF: Mesorectal fascia.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Nomogram for predicting the probability of good downstaging (ypTNM stage 0-I) for all patients. MRF: Mesorectal fascia.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Nomogram for predicting the probability of pathological complete response for the mFOLFOX6-RT regimen. MRF: Mesorectal fascia.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Nomogram for predicting the probability of pathological complete response for the mFOLFOX6 regimen.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Calibration curve of the predicted and observed probabilities of pathological complete response for all patients.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Calibration curve of the predicted and observed probabilities of good downstaging for all patients.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Calibration curve of the predicted and observed probabilities of pathological complete response for the mFOLFOX6-RT regimen.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Calibration curve of the predicted and observed probabilities of pathological complete response for the mFOLFOX6 regimen.